Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic testing predicts virological response in successive protease inhibitor-based regimens.

AIDS (London, England) - 16 Jun 2000

Pérez-Elías M J, Lanier R, Muñoz V, Garcia-Arata I, Casado J L, Marti-Belda P, Moreno A, Dronda F, Antela A, Marco S, Moreno S

Abstract excerpt

OBJECTIVE: To evaluate the importance of the number of active drugs, as determined by phenotypic resistance testing, in achieving virological response in successive salvage regimens. DESIGN: Phenotypic study of 57 plasma samples corresponding to 24 patients who had sequentially received three protease inhibitor-containing regimens. Phenotypic susceptibility to a drug (active drug) was defined as less than a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Confidence Intervals

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Drug Therapy, Combination

Share to HIV Protease Inhibitors

Share to Predictive Value of Tests

Share to Salvage Therapy

Share to Viral Load

Source

Identifiers

PMID: 10894269
DOI: 10.1097/00002030-200006160-00002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic testing predicts virological response in successive protease inhibitor-based regimens.PMID 10894269Read ↗

Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy.Semantic proximity Read ↗

HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice.Semantic proximity Read ↗

Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy.Semantic proximity Read ↗

Resistance to protease inhibitors.Semantic proximity Read ↗

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.Semantic proximity Read ↗

HIV-1 drug resistance assays in clinical management.Semantic proximity Read ↗

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.Semantic proximity Read ↗

Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor.Semantic proximity Read ↗

Resistance of human immunodeficiency virus type 1 to reverse transcriptase and protease inhibitors: genotypic and phenotypic testing.Semantic proximity Read ↗

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.Semantic proximity Read ↗

Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.Semantic proximity Read ↗

Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.